Keith Bruhnsen, assistant director of benefits at the University of Michigan , offered advice to employers on strong cost-containment strategies to manage specialty drug costs at EBN´s 21st Benefits Forum and Expo. “Sometimes there are co-pay challenges to members if the employer has a co-insurance model. I have heard from many specialty pharmacy experts that about $50 is where people start having some difficulties in managing the cost,” Bruhnsen said. Employers need to how their workers are going to respond to co-pays on specialty pharmaceuticals.
More From Employee Benefit News
Benefits Think The most practical healthcare innovation in America isn’t coming from Silicon Valley
Public sectors are approaching chronic disease support out of necessity, leading to benefits that build a stronger workforce.
Ellen Rudolph
WellTheory
Benefits Think Moving to a top-down diagnostic of program value
A financial spreadsheet alone cannot capture the total value and performance of a benefits program, nor can numbers on a ledger guarantee long-term operational success.
Donovan Pyle
Health Compass Consulting
Q&A: BMO’s Melissa Dal Vecchio outlines 3 key benefit trends
The health and welfare leader and 2026 Excellence in Benefits honoree is guiding the bank in navigating them all.
Forging stronger broker-TPA partnerships
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
Benefits Think Predictive analytics become essential as high-cost claimants surge
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.